- Patent Title: Cells comprising engineered nucleic-acid targeting nucleic acids
-
Application No.: US15787705Application Date: 2017-10-18
-
Publication No.: US09957490B1Publication Date: 2018-05-01
- Inventor: Paul Daniel Donohoue , Andrew Paul May
- Applicant: Caribou Biosciences, Inc.
- Applicant Address: US CA Berkeley
- Assignee: Caribou Biosciences, Inc.
- Current Assignee: Caribou Biosciences, Inc.
- Current Assignee Address: US CA Berkeley
- Agent Gary R. Fabian; Barbara G. McClung
- Main IPC: C12N15/113
- IPC: C12N15/113 ; C12N15/90 ; C12N9/22

Abstract:
The present disclosure provides engineered cross-type-nucleic-acid targeting nucleic acids and compositions thereof. Nucleic acid sequences encoding the engineered cross-type-nucleic-acid targeting nucleic acids, as well as expression cassettes, vectors and cells comprising such nucleic acid sequences, are described. Also, methods are disclosed for making and using the engineered cross-type-nucleic-acid targeting nucleic acids and compositions thereof.
Public/Granted literature
- US20180119120A1 Cells Comprising Engineered Nucleic-Acid Targeting Nucleic Acids Public/Granted day:2018-05-03
Information query
IPC分类: